Literature DB >> 15365657

Molecularly defined lactose malabsorption, peak bone mass and bone turnover rate in young finnish men.

N Enattah1, V-V Välimäki, M J Välimäki, E Löyttyniemi, T Sahi, I Järvelä.   

Abstract

Lactose malabsorption (LM; adult-type hypolactasia), an autosomal recessive condition, results from the down-regulation of the activity of lactase enzyme in the intestinal wall. In previous studies the effect of LM on bone mass, bone turnover rate, development of osteoporosis and osteoporotic fractures has remained controversial. We have recently identified a single nucleotide polymorphism (SNP), a C to T change residing 13910 base pairs upstream of the lactase (LCT) gene at chromosome 2q21-22, which shows complete association with lactase persistence, with the C/C-13910 genotype defining LM and the genotypes C/T-13910 and T/T-13910 lactase persistence. The present study was undertaken to examine the relationship of the C/T-13910 polymorphism to peak bone mass, bone turnover rate, and stress fractures among young Finnish men. The study population comprised 234 young men, aged 18.3 to 20.6 years, 184 men were recruits of the Finnish Army, and 50 were men of similar age who had postponed their military service for reasons not related to health. Bone mineral content (BMC), density (BMD), and scan area were measured in the lumbar spine and upper femur by dual-energy X-ray absorptiometry (DXA). Blood was sampled for genotyping of the C/T-13910 polymorphism and determination of serum 25-hydroxyvitamin D (25OHD), intact parathyroid hormone (iPTH), type I procollagen aminoterminal propeptide (PINP), and tartrate-resistant acid phosphatase 5b (TRACP5b). Second-void urine samples were collected for the determination of type I collagen aminoterminal telopeptide (NTX). The prevalence of the C/C-13910-genotype of these young adults did not differ significantly from the corresponding population prevalence of C/C-13910 (17.1% vs 18.1%) among Finnish blood donors. Fifteen recruits of the army experienced a stress fracture; 3 of them (20%) had the C/C-13910-genotype. Calcium intake was similar for the three genotypes as were the unadjusted BMCs, scan areas, and BMDs at different measurement sites. The adjustments for age, height, weight, smoking, alcohol consumption, and physical exercise in the multiple regression analysis did not reveal any significant relationships between the lactase genotypes and BMDs at lumbar (P = 0.16), femoral neck (P = 0.99) or total hip (P = 0.96) sites. Serum 25OHD, iPTH, and bone marker levels were similar for the C/C-13910 C/T-13910 and T/T-13910 genotypes. In summary, in young Finnish men, molecularly defined lactose malabsorption does not alter bone turnover rate and impair the acquisition of peak bone mass. Moreover, the C/C-13910 genotype does not seem to be a risk factor for stress fractures in army recruits.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365657     DOI: 10.1007/s00223-004-0029-9

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  12 in total

Review 1.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

2.  Association of lactase 13910 C/T polymorphism with bone mineral density and fracture risk: a meta-analysis.

Authors:  Yougen Wu; Yinghua Li; Yunqing Cui; Yunjiao Zhou; Qingqing Qian; Yang Hong
Journal:  J Genet       Date:  2017-12       Impact factor: 1.166

3.  Adult-type hypolactasia and calcium availability: decreased calcium intake or impaired calcium absorption?

Authors:  B M Obermayer-Pietsch; M Gugatschka; S Reitter; W Plank; A Strele; D Walter; C Bonelli; W Goessler; H Dobnig; C Högenauer; W Renner; A Fahrleitner-Pammer
Journal:  Osteoporos Int       Date:  2006-11-14       Impact factor: 4.507

4.  Calcium supply, bone mineral density and genetically defined lactose maldigestion in a cohort of elderly men.

Authors:  M Gugatschka; A Hoeller; A Fahrleitner-Pammer; H Dobnig; P Pietschmann; S Kudlacek; B Obermayer-Pietsch
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

5.  LCT 13910 C/T polymorphism, serum calcium, and bone mineral density in postmenopausal women.

Authors:  K Bácsi; J P Kósa; A Lazáry; B Balla; H Horváth; A Kis; Z Nagy; I Takács; P Lakatos; G Speer
Journal:  Osteoporos Int       Date:  2008-08-13       Impact factor: 4.507

Review 6.  Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

Authors:  Lorena Rodríguez-Bores; Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

7.  Absence of the lactase-persistence-associated allele in early Neolithic Europeans.

Authors:  J Burger; M Kirchner; B Bramanti; W Haak; M G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

8.  Assessment of vitamin D status and serum CrossLaps levels in adults with primary lactose malabsorption.

Authors:  D Enko; G Kriegshäuser; R Stolba; H Mangge; D Brandstetter; N Mayr; T Forstner; G Halwachs-Baumann
Journal:  Eur J Clin Nutr       Date:  2016-04-27       Impact factor: 4.016

9.  Association of the European lactase persistence variant (LCT-13910 C>T polymorphism) with obesity in the Canary Islands.

Authors:  Ricardo Almon; Eva Elisa Álvarez-León; Lluís Serra-Majem
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

10.  European lactase persistence genotype shows evidence of association with increase in body mass index.

Authors:  Johannes Kettunen; Kaisa Silander; Olli Saarela; Najaf Amin; Martina Müller; Nicholas Timpson; Ida Surakka; Samuli Ripatti; Jaana Laitinen; Anna-Liisa Hartikainen; Anneli Pouta; Päivi Lahermo; Verneri Anttila; Satu Männistö; Antti Jula; Jarmo Virtamo; Veikko Salomaa; Terho Lehtimäki; Olli Raitakari; Christian Gieger; Erich H Wichmann; Cornelia M Van Duijn; George Davey Smith; Mark I McCarthy; Marjo-Riitta Järvelin; Markus Perola; Leena Peltonen
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.